scispace - formally typeset
G

Ghazala Irfan

Researcher at Université libre de Bruxelles

Publications -  26
Citations -  1220

Ghazala Irfan is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Atrial fibrillation & Brugada syndrome. The author has an hindex of 17, co-authored 22 publications receiving 1074 citations. Previous affiliations of Ghazala Irfan include Vrije Universiteit Brussel.

Papers
More filters
Journal ArticleDOI

Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.

TL;DR: ICD therapy was an effective strategy in Brugada syndrome, treating potentially lethal arrhythmias in 17% of patients during long-term follow-up, and risk stratification by electrophysiologic study may identify asymptomatic patients at risk for arrhythmic events and could be helpful in investigating syncope not related to VAs.
Journal ArticleDOI

Single 3-minute freeze for second-generation cryoballoon ablation: One-year follow-up after pulmonary vein isolation

TL;DR: A single 3-minute freeze is highly effective, determining an atrial tachyarrhythmia freedom of 80.4% at 1-year follow-up, and Routine use of an "insurance freeze" may not be needed.
Journal ArticleDOI

Circumferential pulmonary vein isolation as index procedure for persistent atrial fibrillation: a comparison between radiofrequency catheter ablation and second-generation cryoballoon ablation

TL;DR: Atrial tachyarrhythmias occurrence during BP and longer time of PersAF seem to be significant predictors of arrhythmia recurrences after the index procedure, which is associated with shorter procedure time and radiation exposure as compared with RFCA.
Journal ArticleDOI

Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience.

TL;DR: Programmed ventricular stimulation of the heart is a good predictor of outcome in individuals with Brugada syndrome and might be of special value to guide further management when performed in asymptomatic individuals.